CClinicalTrials.gg
Not yet recruitingNCT07273682Updated Dec 9, 2025

Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors

An interventional study of Counseling based on Omaha system and Usual Care in Pediatric Cancer, sponsored by The Hong Kong Polytechnic University. Not yet recruiting. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-09.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
All
01

Study summary

This study aims to evaluate the feasibility and preliminary effectiveness of a nurse-facilitated interdisciplinary transitional care programme, based on the Omaha system, for Chinese childhood cancer survivors (CCSs) and their parents in Hong Kong. Investigators will conduct a two-arm, randomized waitlist-controlled trial at the Hong Kong Children's Hospital, the only local center for CCS follow-up. Sixty-eight dyads (CCS aged 13-18 and a parent) will be randomized to either the 12-week nurse-led intervention or usual care. The intervention includes an initial face-to-face assessment and regular follow-ups via Zoom, focusing on symptom management, health education, and self-care empowerment, with referrals to other professionals as needed. The control group receives standard discharge care and educational materials, and will be offered the intervention after data collection. Outcomes will be assessed at baseline, and 3 and 6 months post-intervention, including symptom management, quality of life, caregiver burden, self-efficacy, and emergency department visits. Feasibility will be evaluated by recruitment, retention, attendance, and data completeness rates. If effective, this programme could improve transitional care and symptom management for CCSs and their families, and inform clinical practice and policy in Hong Kong and beyond.

02

Conditions studied

  • Pediatric Cancer

Browse trials for

Keywords

  • Omaha system
  • nurse-facilitated
  • interdisciplinary transitional care programme
  • Chinese childhood cancer survivors
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's planned enrollment of 68 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for CCSs:

  • aged between 13 and 18 years
  • diagnosed with any cancer
  • completion of active cancer treatment within a month
  • communicate in Chinese

Inclusion Criteria for parents:

  • mother or father who has a significant caregiving role in the child's life
  • could participate in the intervention at the same time as their child
  • communicate in Chinese
  • have an electronic device to access zoom

Exclusion Criteria for CCSs:

  • cognitive impairment
  • social and/or behavioural problem
  • have terminal cancer
  • participate in any similar intervention

Exclusion Criteria for parents:

  • severe emotional problems
  • participate in any similar intervention
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Other: Counseling based on Omaha system

  • Other
    Wait-list control group

    Other: Counseling based on Omaha system · Other: Usual Care

Interventions

  • OtherCounseling based on Omaha system

    Investigators developed the intervention based on the Omaha system and investigators' previous studies. The intervention will last for 12 weeks. During week 1, dyads (a pairing of a child with their parent) will have a 1-hour face-to-face consultation with a RN. The RN will assess every dyad using the Omaha system to identify any problems. The Omaha system covers 42 problems grouped into 4 categories, including environmental, physiological, psychosocial and health-related behaviours. After identifying the problems, the RN will deliver corresponding interventions according to the intervention scheme in the Omaha system. Subsequent follow-up will be provided by the RN via zoom during weeks 2, 3, 4, 6, 8, 10 and 12 to evaluate their progress in terms of knowledge, behaviour and status using the rating scale in the Omaha system. The RN will assign further interventions, based on the Omaha system, to address their specific needs. Each follow-up should last around 30 minutes.

  • OtherUsual Care

    Dyads in this group will receive usual care, defined as the existing care practices provided by the hospital, which include a discharge checklist and educational materials regarding the care. After the completion of data collection for all timepoints, they will be invited to join the counselling based on Omaha system intervention.

06

What researchers measure

Primary outcomes

  1. Screening rate

    Number of dyads screened divided by number of dyads available for screening.

    Time frame: Baseline

  2. Eligibility rate

    Number of dyads eligible divided by number of dyads screened.

    Time frame: Baseline

  3. Recruitment rate

    Number of eligible dyads agree to join divided by number of eligible dyads.

    Time frame: Baseline

  4. Randomization rate

    Number of dyads being randomized divided by number of participating dyads.

    Time frame: Baseline

  5. Intervention attendance rate

    Number of dyads who complete the intervention divided by number of dyads in the intervention group.

    Time frame: Immediately after the intervention completion

  6. Retention rate

    Number of dyads remaining in the study divided by number of dyads being randomized.

    Time frame: Baseline, immediately after the intervention completion, 3 months after intervention completion, 6 months after intervention completion

  7. Completion rate

    Number of dyads who complete the questionnaire divided by number of questionnaires distributed.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  8. Missing data

    Percentage of missing data

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  9. Adverse events

    Number of unfavourable events and/or worsening reported.

    Time frame: During the study period including 12-week intervention and 6 months follow-up

Secondary outcomes

  1. Cancer-related symptoms in CCSs

    It will be used to assess the cancer-related symptoms in CCSs. It has 30 items in seven domains: nutrition-related, psychosocial/central nervous system, oropharyngeal, bone marrow toxicity/neuropathy, skin/other toxicities, neurotoxicity and respiratory/other. Each item will be evaluated on a five-point scale, from 0 to 4. The psychometric properties have been well validated in CCSs.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  2. CCSs' quality of life (QoL)

    Paediatric Quality of Life Questionnaire (PedsQoL) will be used to assess the CCSs' QoL. It comprises 23 items. CCSs will rate their experience during the preceding month on a five-point scale. All items will be reverse-scored and linearly transformed onto a 0-100-point scale. This scale has well-established psychometric properties in CCSs.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  3. Caregiver burden of parents

    The caregiver burden in parents will be assessed using the Chinese version of the Caregiver burden inventory (CBI), which consists of 24 items in five dimensions: time-dependence, development, physical, social and emotional burdens. Each item will be evaluated from 0 (not at all relevant) to 4 (very relevant), with the total score between 0 and 96. The Chinese version is a valid and reliable instrument for use.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  4. Caregiving competence of parents

    Caregiving competence scale (CCS) will be used to record the competence of parents regarding their caregiving. This scale comprises four items, each of which is evaluated on a four-point rating scale, from 1 (not at all) to 4 (very much). The psychometric properties of the Chinese version have been well established.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  5. Parental quality of life (QoL)

    Parental QoL will be assessed using the Chinese version of the EQ-5D, with one question regarding each of five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The values will be weighted to convert into a value from 1 (full health) to 0 (equivalent to being dead). The psychometric properties of the EQ-5D have been well validated in the Chinese population.

    Time frame: Baseline, immediately after the intervention completion, 3 months after the intervention completion, 6 months after the intervention completion

  6. Number of emergency department (ED) visits

    It will be assessed by number of walk-in visits to the emergency department. These data will be collected in the central medical system with the assistance of PI in HKCH (Hong Kong Children's Hospital).

    Time frame: During the study period including 12-week intervention and 6 months follow up

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07273682
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
Dr Eva Ho (associate professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Dec 9, 2025
Start date
Jul 1, 2026 (estimated)
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Dec 9, 2025

Study contacts

Ka Yan Ho
Contact
kyeva.ho@polyu.edu.hk
+8527666417

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion